PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22536875-1	2012	AIM:   IL28B polymorphisms serve to predict response to pegylated interferon plus ribavirin therapy (PEG IFN/RBV) in Japanese patients with chronic hepatitis C (CHC) very reliably.	peg ifn	101-108	interferon lambda 3	Homo sapiens	7-12	
22536875-2	2012	However, the prediction by the IL28B polymorphism contradicted the virological response to PEG IFN/RBV in some patients.	peg ifn	91-98	interferon lambda 3	Homo sapiens	31-36